Drugs / EC905
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02634489 Comparator | Mar → Jul 2009 | benign prostatic hyperplasia | Astellas Pharma Europe B.V. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT06546735 Comparator | Nov 2026 → Apr 2028 expected | benign prostatic hyperplasia | Eurofarma Laboratorios S.A. | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EC905 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02634489 ↗ |
| Known as | Vesomni | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06546735 ↗ |
| Route | Oral | “Oral” NCT02634489 ↗ |